NOV 02, 2020 7:34 PM PST

Type 2 Diabetic Drug Combo Proves Effective

WRITTEN BY: Nouran Amin

A common first-line therapeutic for type 2 diabetes is the metformin drug used to stabilize blood glucose levels. Although the drug is effective, some type 2 diabetic patients will stop responding to metformin.  

Learn more about metformin:

As a result, a clinical trial launched a few years ago to address this challenge. The trial involved two-drugs combo of dapagliflozin and exenatide that was recently shown to be effective after two years of continual use.

"Many therapies in diabetes management are short-lived, which is why it's useful to test for long-term effect," says senior author Serge Jabbour, MD, director of the division of endocrinology and the Diabetes Center at Thomas Jefferson University. "Our study showed that a combo regimen of dapagliflozin and exenatide continued to control patients' glucose for over two years. This is a very encouraging."

Findings were published in Diabetes Care.

"These two classes work synergistically to help control a Type-2 diabetes patient's glucose levels, and other measures associated with diabetes," says Dr. Jabbour. "We can now feel more confident about prescribing these medications long term."

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
SEP 23, 2021
Cannabis Sciences
Inflammatory Bowel Disease and Cannabis- A Quality of Life Question
SEP 23, 2021
Inflammatory Bowel Disease and Cannabis- A Quality of Life Question
Inflammatory Bowel Disease (IBD) is a term used to describe chronic inflammation of the gastrointestinal tract. In gener ...
OCT 07, 2021
Drug Discovery & Development
Extended approval for a drug to treat children living with HIV
OCT 07, 2021
Extended approval for a drug to treat children living with HIV
On Monday October 4th, ViiV Healthcare announced that it had submitted an application to the United States Food and Drug ...
OCT 14, 2021
Immunology
'Bio-Betters' Form the Next Wave of Cancer Therapies
OCT 14, 2021
'Bio-Betters' Form the Next Wave of Cancer Therapies
  Antibodies are blood proteins with highly specialized functions: to recognize and eliminate bacteria, viruses, an ...
OCT 19, 2021
Microbiology
An Antibiotic May be Able to Reduce Inflammatory Pain
OCT 19, 2021
An Antibiotic May be Able to Reduce Inflammatory Pain
The gastrointestinal tract is full of microbes, all with their own genomes and characteristics. Some of those microbes a ...
NOV 19, 2021
Genetics & Genomics
Transcriptomics Method Can Reveal Genes Behind Venom Production
NOV 19, 2021
Transcriptomics Method Can Reveal Genes Behind Venom Production
Some of our best medications have come from nature. For years, researchers have been studying the properties of differen ...
DEC 01, 2021
Drug Discovery & Development
Researchers develop a novel drug that can combat diabetic tissue damage
DEC 01, 2021
Researchers develop a novel drug that can combat diabetic tissue damage
Diabetes is a common disease that occurs when high levels of blood sugar start to silently damage bodily tissue and orga ...
Loading Comments...